SEC Form 4 · accession 0001061983-26-000094
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert I Blum
Officer — President & CEO · Director
Period of report
Sep 14, 2026
Accepted (ET)
Sep 15, 2026 · 5:20 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2026 | M | 7,500 | $10.60 | A | 385,320 | D | |
| Common Stock | Sep 14, 2026 | S | 7,500 | $73.44 | D | 377,820 | D | |
| Common Stock | Sep 14, 2026 | G | 1,350 | $0.00 | D | 376,470 | D | |
| Common Stock | Sep 14, 2026 | G | 97,926 | $0.00 | D | 278,544 | D | |
| Common Stock | Sep 14, 2026 | G | 97,926 | $0.00 | A | 97,926 | I | by Trust 3. Beneficial Ownership Disclaimed. |
| Common Stock | Sep 15, 2026 | S | 97,926 | $69.33 | D | 0 | I | by Trust 3. Beneficial Ownership Disclaimed. |
| Common StockF7 | holding | — | — | — | 2,083 | I | by Trust 1. Beneficial Ownership disclaimed. | |
| Common StockF8 | holding | — | — | — | 2,083 | I | by Trust 2. Beneficial Ownership Disclaimed. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) | $10.60 | Sep 14, 2026 | M | 7,500 | D | Mar 28, 2017 | Feb 28, 2027 | Common Stock | 7,500 | 156,745 | D |
Explanation of responses
- F1Acquisition of shares of common stock upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c).
- F2Sale of shares of common stock acquired upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c).
- F3Charitable gift.
- F4Transfer of shares of common stock to The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares held by the aforementioned trust upon completion of the gift transfer.
- F5Acquisition of shares by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares held by the aforementioned trust.
- F6Sale of shares of common stock by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares sold or the proceeds thereof.
- F7Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
- F8Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
- F9Exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c).